Taryn Fritz Walpole joined the Validant Group’s executive team following more than two decades of strategic communications, regulatory, and marketing experience that includes leadership roles on Capitol Hill and at the U.S. Food and Drug Administration (FDA).

Prior to her role as Chief Marketing Officer, Taryn served as Chief of Staff and Executive Vice President, Regulatory Affairs at Greenleaf Health, a business unit of the Validant Group. In this capacity, Taryn was responsible for Greenleaf’s marketing and communications programs, including new product launches, enhanced service offerings, and corporate campaigns. During her 14+ years at Greenleaf, Taryn led the firm’s cross-cutting initiatives and corporate programs. Taryn also provided guidance to clients on projects spanning medical products, regulatory compliance, and FDA engagement strategy. 

Taryn joined Greenleaf following five years of service at the U.S. Food and Drug Administration (FDA), most recently in the role of Deputy Chief of Staff. In this capacity, Taryn planned and executed all of the FDA’s priority announcements, high-profile public health actions, and medical product crisis incidents on a wide variety of issues.

During her FDA tenure, Taryn played a leading role in the creation and implementation of FDA’s first process plans for coordinating public announcements and managing crisis situations, including message platforms, communications and outreach strategies, and tactical activities.

Taryn began her FDA career following a decade of service as a senior staffer for Capitol Hill lawmakers. Taryn’s leadership roles included service as the Senior Advisor and Communications Director for US Rep. Henry Bonilla, and Deputy Press Secretary for US Sen. Kay Bailey Hutchison.

Taryn received a B.A. from Southern Methodist University, with a dual major in Communications/Journalism and Political Science.